Over the past two years, the ratio of bankruptcy documents rises in 2025 with companies that continue to apply.
The annual bankruptcy documents have been less than 10 years, but in 2023 in 2023 and 13 in 13 this year in 20010, this year was the highest since 2010.
💵💰Don’t miss the action: Subscribe to TheStreet’s Free Daily Bulletin💰💵
Last year, there was a very sclerosis treatment and many sclerosis treatment given to Acora therapeutics, Pearl River, NY, Parkinson’s disease and chapter 11 in April 1, 2024.
Related: Chapter 11 documents of another great health company
In May 13, 2024, Gamida Cell Inc, which develops stem cell therapies for several blood cancers and several blood cancers and other disorders with leukemia and lymphoma
In 2025, companies appealed on 11 chapters 11, in the first operation supported by the advanced in the first operation, with a support agreement supported by advanced medicines, the amount of liabilities and treatment with a loan proposal to the debtor.
Austin, Texas-based biotechnology company Molecular Templats Inc., which develops cancer treatment medications, plans to deliver the bankruptcy in April 11, 2025 in April 11, 2025, the lender provided by the reconstruction support agreement.
Picture Source: Getty Images
Synthego files in Chapter 11
Finally, a difficult biotechnology company Synthego Corp. In the chapter on May 11, the chapter for the protection of bankruptcy on May 11, he wanted to sell his activity before his lender.
Related: Basic Health Provider Documents Chapter 11 Bankruptcy
Debtor $ 50 million, up to $ 100 million, including $ 100 million, including $ 73.4 million, including $ 73.4 million, including $ 73.4 million, including $ 73.4 million, including $ 73.4 million
More bankruptcy:
- Iconic Auto Repair chain franchise files in Chapter 11
- Popular beer brand closes and chapter 7 bankruptcy
- Chapter 11 Popular vodka and gin brand documents
The debtor’s largest unsecured creditors, the Wellington Hadley Port, which is $ 51 million, includes master investors; The 8VC Joint Investment Fund was owed I, $ 37.1 million; And the 8vc background i LP owes $ 15 million.
The debtor, the reporter’s head reconstruction officer Allen Soong, the world’s largest research and basic research and basic research and the sale of biofarmomeutic companies have resulted in rapid growth and solutions.
The increase in revenue resulted in the cost and investment required to support its technologies continuously, which led to a reduction and increase in operation.
Thestreet
The company raised capital to continue its operations, but by the end of 2023, the company did not have a positive cash flow and its size increased more than 10 times in 2020-2021.
In the spring of 2024, the company reduced the loss of operating, but in February 2025, in February 2025, it has not been enough to serve its debt, which has sold its engineering.
The company has determined that the company’s best choice to protect the value of the applicant enterprise for protection against chapter 11, protecting work operations and organize the sale of the company.
The debtor has a $ 37.5 million debtor, a $ 37.5 million debtor, $ 50 million, $ 5 million, with $ 5 million, a new money in the intermedical order.
Synthego won temporary approval of the loan of dip loan on May 9.
Synthego trying to sell assets
The debtor also wants to receive a bankruptcal sale of a bankrupt offer with a loan offer, as well as a loan offer, as well as $ 12.5 million debt, as well as a bankrupt offer.
Stalking At the same time, 1.5% of the loan proposal is a proposal to pay up to $ 1 million, and receive more than a $ 500,000 over $ 500,000.
San Mateo, which is a caliable in 2012, produces genetic products to sell genetic products, medicines and research and research and academic institutions such as RNAs. REDWOOD City operates a production facility in Calif.
Synthego’s customer base consists of 25% of pharmaceutical and biotechnology companies, 50% small and medium-sized biotechnology companies and 25% Academic Medical Center.
Related: Basic Medical Company documents in Chapter 7
